Global Personalized Cancer Medicine Market Research Report 2025(Status and Outlook)

Report Overview

Personalized cancer medicine, also known as precision oncology, refers to the tailored approach of diagnosing and treating cancer based on an individual's unique genetic, molecular, and clinical profile. This method leverages advanced diagnostic tools such as genomic sequencing, biomarker analysis, and liquid biopsies to identify specific mutations or alterations driving a patient's cancer. By targeting these unique characteristics, therapies—including targeted drugs, immunotherapies, or combination treatments—can be optimized for higher efficacy and reduced side effects compared to traditional one-size-fits-all approaches like chemotherapy. The field integrates multidisciplinary insights from genomics, bioinformatics, and pharmacology to enable data-driven decision-making, improving patient outcomes and reshaping cancer care paradigms.

The global Personalized Cancer Medicine market size was estimated at USD 3803.52 million in 2024, exhibiting a CAGR of 12.34% during the forecast period.

This report provides a deep insight into the global Personalized Cancer Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Personalized Cancer Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Personalized Cancer Medicine market in any manner.

Global Personalized Cancer Medicine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AbbVie

Johnson & Johnson

Novartis

Gilead Sciences

Roche

Bristol-Myers Squibb

Amgen

AstraZeneca

Merck & Co

Takeda

Merck KGaA

Seagen

Eli Lilly

Ono Pharmaceutical

Pfizer

GSK

Exelixis

Regeneron

Innovent

Hengrui Medicine

Market Segmentation (by Type)

Cancer Immunotherapy

Targeted Therapy

Market Segmentation (by Application)

Lung Cancer

Breast Cancer

Prostate Cancer

Blood-related Cancer

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Personalized Cancer Medicine Market

Overview of the regional outlook of the Personalized Cancer Medicine Market:

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Personalized Cancer Medicine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Personalized Cancer Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Personalized Cancer Medicine
1.2 Key Market Segments
1.2.1 Personalized Cancer Medicine Segment by Type
1.2.2 Personalized Cancer Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Personalized Cancer Medicine Market Overview
2.1 Global Market Overview
2.1.1 Global Personalized Cancer Medicine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Personalized Cancer Medicine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Personalized Cancer Medicine Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Personalized Cancer Medicine Product Life Cycle
3.3 Global Personalized Cancer Medicine Sales by Manufacturers (2020-2025)
3.4 Global Personalized Cancer Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Personalized Cancer Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Personalized Cancer Medicine Market Competitive Situation and Trends
3.8.1 Personalized Cancer Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Personalized Cancer Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Personalized Cancer Medicine Industry Chain Analysis
4.1 Personalized Cancer Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Personalized Cancer Medicine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Personalized Cancer Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Personalized Cancer Medicine Market
5.7 ESG Ratings of Leading Companies
6 Personalized Cancer Medicine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Personalized Cancer Medicine Sales Market Share by Type (2020-2025)
6.3 Global Personalized Cancer Medicine Market Size Market Share by Type (2020-2025)
6.4 Global Personalized Cancer Medicine Price by Type (2020-2025)
7 Personalized Cancer Medicine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Personalized Cancer Medicine Market Sales by Application (2020-2025)
7.3 Global Personalized Cancer Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Personalized Cancer Medicine Sales Growth Rate by Application (2020-2025)
8 Personalized Cancer Medicine Market Sales by Region
8.1 Global Personalized Cancer Medicine Sales by Region
8.1.1 Global Personalized Cancer Medicine Sales by Region
8.1.2 Global Personalized Cancer Medicine Sales Market Share by Region
8.2 Global Personalized Cancer Medicine Market Size by Region
8.2.1 Global Personalized Cancer Medicine Market Size by Region
8.2.2 Global Personalized Cancer Medicine Market Size Market Share by Region
8.3 North America
8.3.1 North America Personalized Cancer Medicine Sales by Country
8.3.2 North America Personalized Cancer Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Personalized Cancer Medicine Sales by Country
8.4.2 Europe Personalized Cancer Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Personalized Cancer Medicine Sales by Region
8.5.2 Asia Pacific Personalized Cancer Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Personalized Cancer Medicine Sales by Country
8.6.2 South America Personalized Cancer Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Personalized Cancer Medicine Sales by Region
8.7.2 Middle East and Africa Personalized Cancer Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Personalized Cancer Medicine Market Production by Region
9.1 Global Production of Personalized Cancer Medicine by Region(2020-2025)
9.2 Global Personalized Cancer Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Personalized Cancer Medicine Production
9.4.1 North America Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.4.2 North America Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Personalized Cancer Medicine Production
9.5.1 Europe Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Personalized Cancer Medicine Production (2020-2025)
9.6.1 Japan Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Personalized Cancer Medicine Production (2020-2025)
9.7.1 China Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.7.2 China Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 AbbVie
10.1.1 AbbVie Basic Information
10.1.2 AbbVie Personalized Cancer Medicine Product Overview
10.1.3 AbbVie Personalized Cancer Medicine Product Market Performance
10.1.4 AbbVie Business Overview
10.1.5 AbbVie SWOT Analysis
10.1.6 AbbVie Recent Developments
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Basic Information
10.2.2 Johnson and Johnson Personalized Cancer Medicine Product Overview
10.2.3 Johnson and Johnson Personalized Cancer Medicine Product Market Performance
10.2.4 Johnson and Johnson Business Overview
10.2.5 Johnson and Johnson SWOT Analysis
10.2.6 Johnson and Johnson Recent Developments
10.3 Novartis
10.3.1 Novartis Basic Information
10.3.2 Novartis Personalized Cancer Medicine Product Overview
10.3.3 Novartis Personalized Cancer Medicine Product Market Performance
10.3.4 Novartis Business Overview
10.3.5 Novartis SWOT Analysis
10.3.6 Novartis Recent Developments
10.4 Gilead Sciences
10.4.1 Gilead Sciences Basic Information
10.4.2 Gilead Sciences Personalized Cancer Medicine Product Overview
10.4.3 Gilead Sciences Personalized Cancer Medicine Product Market Performance
10.4.4 Gilead Sciences Business Overview
10.4.5 Gilead Sciences Recent Developments
10.5 Roche
10.5.1 Roche Basic Information
10.5.2 Roche Personalized Cancer Medicine Product Overview
10.5.3 Roche Personalized Cancer Medicine Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Basic Information
10.6.2 Bristol-Myers Squibb Personalized Cancer Medicine Product Overview
10.6.3 Bristol-Myers Squibb Personalized Cancer Medicine Product Market Performance
10.6.4 Bristol-Myers Squibb Business Overview
10.6.5 Bristol-Myers Squibb Recent Developments
10.7 Amgen
10.7.1 Amgen Basic Information
10.7.2 Amgen Personalized Cancer Medicine Product Overview
10.7.3 Amgen Personalized Cancer Medicine Product Market Performance
10.7.4 Amgen Business Overview
10.7.5 Amgen Recent Developments
10.8 AstraZeneca
10.8.1 AstraZeneca Basic Information
10.8.2 AstraZeneca Personalized Cancer Medicine Product Overview
10.8.3 AstraZeneca Personalized Cancer Medicine Product Market Performance
10.8.4 AstraZeneca Business Overview
10.8.5 AstraZeneca Recent Developments
10.9 Merck and Co
10.9.1 Merck and Co Basic Information
10.9.2 Merck and Co Personalized Cancer Medicine Product Overview
10.9.3 Merck and Co Personalized Cancer Medicine Product Market Performance
10.9.4 Merck and Co Business Overview
10.9.5 Merck and Co Recent Developments
10.10 Takeda
10.10.1 Takeda Basic Information
10.10.2 Takeda Personalized Cancer Medicine Product Overview
10.10.3 Takeda Personalized Cancer Medicine Product Market Performance
10.10.4 Takeda Business Overview
10.10.5 Takeda Recent Developments
10.11 Merck KGaA
10.11.1 Merck KGaA Basic Information
10.11.2 Merck KGaA Personalized Cancer Medicine Product Overview
10.11.3 Merck KGaA Personalized Cancer Medicine Product Market Performance
10.11.4 Merck KGaA Business Overview
10.11.5 Merck KGaA Recent Developments
10.12 Seagen
10.12.1 Seagen Basic Information
10.12.2 Seagen Personalized Cancer Medicine Product Overview
10.12.3 Seagen Personalized Cancer Medicine Product Market Performance
10.12.4 Seagen Business Overview
10.12.5 Seagen Recent Developments
10.13 Eli Lilly
10.13.1 Eli Lilly Basic Information
10.13.2 Eli Lilly Personalized Cancer Medicine Product Overview
10.13.3 Eli Lilly Personalized Cancer Medicine Product Market Performance
10.13.4 Eli Lilly Business Overview
10.13.5 Eli Lilly Recent Developments
10.14 Ono Pharmaceutical
10.14.1 Ono Pharmaceutical Basic Information
10.14.2 Ono Pharmaceutical Personalized Cancer Medicine Product Overview
10.14.3 Ono Pharmaceutical Personalized Cancer Medicine Product Market Performance
10.14.4 Ono Pharmaceutical Business Overview
10.14.5 Ono Pharmaceutical Recent Developments
10.15 Pfizer
10.15.1 Pfizer Basic Information
10.15.2 Pfizer Personalized Cancer Medicine Product Overview
10.15.3 Pfizer Personalized Cancer Medicine Product Market Performance
10.15.4 Pfizer Business Overview
10.15.5 Pfizer Recent Developments
10.16 GSK
10.16.1 GSK Basic Information
10.16.2 GSK Personalized Cancer Medicine Product Overview
10.16.3 GSK Personalized Cancer Medicine Product Market Performance
10.16.4 GSK Business Overview
10.16.5 GSK Recent Developments
10.17 Exelixis
10.17.1 Exelixis Basic Information
10.17.2 Exelixis Personalized Cancer Medicine Product Overview
10.17.3 Exelixis Personalized Cancer Medicine Product Market Performance
10.17.4 Exelixis Business Overview
10.17.5 Exelixis Recent Developments
10.18 Regeneron
10.18.1 Regeneron Basic Information
10.18.2 Regeneron Personalized Cancer Medicine Product Overview
10.18.3 Regeneron Personalized Cancer Medicine Product Market Performance
10.18.4 Regeneron Business Overview
10.18.5 Regeneron Recent Developments
10.19 Innovent
10.19.1 Innovent Basic Information
10.19.2 Innovent Personalized Cancer Medicine Product Overview
10.19.3 Innovent Personalized Cancer Medicine Product Market Performance
10.19.4 Innovent Business Overview
10.19.5 Innovent Recent Developments
10.20 Hengrui Medicine
10.20.1 Hengrui Medicine Basic Information
10.20.2 Hengrui Medicine Personalized Cancer Medicine Product Overview
10.20.3 Hengrui Medicine Personalized Cancer Medicine Product Market Performance
10.20.4 Hengrui Medicine Business Overview
10.20.5 Hengrui Medicine Recent Developments
11 Personalized Cancer Medicine Market Forecast by Region
11.1 Global Personalized Cancer Medicine Market Size Forecast
11.2 Global Personalized Cancer Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Personalized Cancer Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Personalized Cancer Medicine Market Size Forecast by Region
11.2.4 South America Personalized Cancer Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Personalized Cancer Medicine by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Personalized Cancer Medicine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Personalized Cancer Medicine by Type (2026-2033)
12.1.2 Global Personalized Cancer Medicine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Personalized Cancer Medicine by Type (2026-2033)
12.2 Global Personalized Cancer Medicine Market Forecast by Application (2026-2033)
12.2.1 Global Personalized Cancer Medicine Sales (K Units) Forecast by Application
12.2.2 Global Personalized Cancer Medicine Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings